The FY2025 (Dec) proxy of Amylyx Pharmaceuticals names 18 peer companies for pay. Pay versus performance data of Amylyx Pharmaceuticals for that year is not on file, so it has no rank.
Pay peer group, FY2025 (Dec) proxy
| CytomX Therapeutics | ||
| aTYR Pharma | ||
| Aclaris Therapeutics, Inc. | Not disclosed | Not disclosed |
| Adverum Biotechnologies, Inc. | Not disclosed | Not disclosed |
| Aura Biosciences | Not disclosed | Not disclosed |
| BioAtla, Inc. | Not disclosed | Not disclosed |
| Biomea Fusion, Inc. | Not disclosed | Not disclosed |
| Chimerix, Inc. | Not disclosed | Not disclosed |
| Gossamer Bio, Inc. | Not disclosed | Not disclosed |
| Immunic, Inc. | Not disclosed | Not disclosed |
| Inozyme Pharma, Inc. | Not disclosed | Not disclosed |
| PepGen Inc. | Not disclosed | Not disclosed |
| Pyxis Oncology, Inc. | Not disclosed | Not disclosed |
| RAPT Therapeutics, Inc. | Not disclosed | Not disclosed |
| Syros Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Verastem, Inc. | Not disclosed | Not disclosed |
| Vigil Neuroscience, Inc. | Not disclosed | Not disclosed |
| XBiotech Inc. | Not disclosed | Not disclosed |
18 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.